These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2201252)

  • 21. Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients.
    Shah PM; Heller A; Fuhr HG; Walther F; Halir S; Schaumann R; Böhme A; Jung B; Köhler A; Lips-Schulte C; Stille W
    Infection; 1996; 24(6):480-4. PubMed ID: 9007599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
    Biron P; Fuhrmann C; Cure H; Viens P; Lefebvre D; Thyss A; Viot M; Soler-Michel P; Rollin C; Grès JJ
    J Antimicrob Chemother; 1998 Oct; 42(4):511-8. PubMed ID: 9818751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
    Behre G; Link H; Maschmeyer G; Meyer P; Paaz U; Wilhelm M; Hiddemann W
    Ann Hematol; 1998 Feb; 76(2):73-80. PubMed ID: 9540761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.
    de Pauw B; Williams K; de Neeff J; Bothof T; de Witte T; Holdrinet R; Haanen C
    Antimicrob Agents Chemother; 1985 Dec; 28(6):824-8. PubMed ID: 3909956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
    Riikonen P
    Pediatr Infect Dis J; 1991 Dec; 10(12):918-23. PubMed ID: 1766707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial agents in neutropenic patients with unexplained fever.
    Shevchuk YM
    J Infect Dis; 1991 Jan; 163(1):203. PubMed ID: 1984471
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
    Au E; Tow A; Allen DM; Ang PT
    Ann Acad Med Singap; 1994 Nov; 23(6):819-22. PubMed ID: 7741492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftriaxone versus imipenem/cilastatin as empirical monotherapy for infections in cancer patients.
    Bucaneve G; Menichetti F; Minotti V; Pasticci MB; Tonato M; Del Favero A
    Chemotherapy; 1989; 35 Suppl 2():10-5. PubMed ID: 2612235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
    Figuera A ; Rivero N; Pajuelo F; Font P; Leyra F; de La Cámara R; Arranz R; María Fernández Rañada J
    Med Clin (Barc); 2001 May; 116(16):610-1. PubMed ID: 11412645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients.
    Engervall P; Günther G; Ljungman P; Lönnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Björkholm M
    J Chemother; 1996 Oct; 8(5):382-6. PubMed ID: 8957719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children.
    Jacobs RF; Vats TS; Pappa KA; Chaudhary S; Kletzel M; Becton DL
    Infection; 1993; 21(4):223-8. PubMed ID: 8225625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
    Ho A; Leung R; Lai CK; Chan TH; Chan CH
    Respiration; 1997; 64(3):224-8. PubMed ID: 9154675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.
    Verhagen C; De Pauw BE; Williams KJ; Du Bois W
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):178-82. PubMed ID: 3134208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
    Freifeld AG; Walsh T; Marshall D; Gress J; Steinberg SM; Hathorn J; Rubin M; Jarosinski P; Gill V; Young RC
    J Clin Oncol; 1995 Jan; 13(1):165-76. PubMed ID: 7799016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
    Feliu J; Artal A; González Barón M; Berrocal A; Chacón I; García de Paredes ML; Espinosa E; Ordóñez A; Zamora P; Montero JM
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2816-20. PubMed ID: 1482151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial comparing imipenem/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer.
    Matsui K; Masuda N; Takada M; Kusunoki Y; Fukuoka M
    Jpn J Clin Oncol; 1991 Dec; 21(6):428-34. PubMed ID: 1805048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease.
    Petrilli AS; Melaragno R; Barros KV; Silva AA; Kusano E; Ribeiro RC; Bianchi A
    Pediatr Infect Dis J; 1993 Nov; 12(11):916-21. PubMed ID: 8265281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
    Brismar B; Malmborg AS; Tunevall G; Wretlind B; Bergman L; Mentzing LO; Nyström PO; Kihlström E; Bäckstrand B; Skau T
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.